These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35165229)

  • 1. Logistical Facilitators and Barriers to PrEP Implementation in Methadone Clinic Settings: Provider and Staff Perspectives.
    Jaiswal J; Griffin M; Hascher K; Cox AB; Dunlap K; Walters S; LoSchiavo C; Burton WM; Mumba M
    J Addict Med; 2022 Sep-Oct 01; 16(5):e278-e283. PubMed ID: 35165229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-exposure prophylaxis awareness, acceptability and potential stigma among medical and non-medical clinic staff in methadone treatment settings in northern New Jersey: The key role of non-medical staff in enhancing HIV prevention.
    Jaiswal J; Dunlap K; Griffin M; Cox A; Singer SN; Hascher K; LoSchiavo C; Walters SM; Mumba M
    J Subst Abuse Treat; 2021 Oct; 129():108371. PubMed ID: 34080542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs.
    Harris MT; Weinberger E; O'Brien C; Althoff M; Paltrow-Krulwich S; Taylor JL; Judge A; Samet JH; Walley AY; Gunn CM
    Addict Sci Clin Pract; 2024 Jun; 19(1):47. PubMed ID: 38831359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study.
    Krakower D; Ware N; Mitty JA; Maloney K; Mayer KH
    AIDS Behav; 2014 Sep; 18(9):1712-21. PubMed ID: 24965676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "There hasn't been a push to identify patients in the emergency department"-Staff perspectives on automated identification of candidates for pre-exposure prophylaxis (PrEP): A qualitative study.
    Devlin SA; Johnson AK; Stanford KA; Haider S; Ridgway JP
    PLoS One; 2024; 19(3):e0300540. PubMed ID: 38483939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.
    Nyblade L; Ndirangu JW; Speizer IS; Browne FA; Bonner CP; Minnis A; Kline TL; Ahmed K; Howard BN; Cox EN; Rinderle A; Wechsberg WM
    BMC Public Health; 2022 Oct; 22(1):1916. PubMed ID: 36242000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key stakeholders' perspectives on providing oral pre-exposure prophylaxis as HIV-prevention standard of care in clinical trials in South Africa.
    Beesham I; Milford C; Joseph Davey DL; Smit J; Mansoor LE; Beksinska M
    Afr J AIDS Res; 2023 Apr; 22(1):18-26. PubMed ID: 36951406
    [No Abstract]   [Full Text] [Related]  

  • 8. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provider perspectives on PrEP for adolescent girls and young women in Tanzania: The role of provider biases and quality of care.
    Pilgrim N; Jani N; Mathur S; Kahabuka C; Saria V; Makyao N; Apicella L; Pulerwitz J
    PLoS One; 2018; 13(4):e0196280. PubMed ID: 29702659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unlocking HIV Pre-Exposure Prophylaxis Delivery: Examining the Role of HIV Providers in Pre-Exposure Prophylaxis Care.
    Kenison TC; Badenhop B; Safo S
    AIDS Patient Care STDS; 2020 Jun; 34(6):251-258. PubMed ID: 32484745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges to Providing Integrated HIV Prevention in Substance Use Treatment Settings: Frontline Staff Perspectives on HIV and Sex-Related, Education, Communication and Stigma.
    Jaiswal J; Griffin M; LoSchiavo C; Cox A; Hascher K; Dunlap K; Walters S; Burton WM; Grin B; Mumba M; Eaton E
    Subst Use Misuse; 2023; 58(14):1866-1873. PubMed ID: 37818832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives.
    Surratt HL; Yeager HJ; Adu A; González EA; Nelson EO; Walker T
    Front Psychiatry; 2022; 13():905314. PubMed ID: 35706473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
    Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
    PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating HIV Pre-Exposure Prophylaxis into Family Planning Care: A RE-AIM Framework Evaluation.
    Brant AR; Dhillon P; Hull S; Coleman M; Ye PP; Lotke PS; Folan J; Scott RK
    AIDS Patient Care STDS; 2020 Jun; 34(6):259-266. PubMed ID: 32484743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putting PrEP into Practice: Lessons Learned from Early-Adopting U.S. Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care.
    Calabrese SK; Magnus M; Mayer KH; Krakower DS; Eldahan AI; Gaston Hawkins LA; Hansen NB; Kershaw TS; Underhill K; Betancourt JR; Dovidio JF
    PLoS One; 2016; 11(6):e0157324. PubMed ID: 27304883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults' Perspectives.
    Sun CJ; Anderson KM; Bangsberg D; Toevs K; Morrison D; Wells C; Clark P; Nicolaidis C
    J Gen Intern Med; 2019 Apr; 34(4):535-543. PubMed ID: 30719647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework.
    Kadiamada-Ibarra H; Hawley NL; Sosa-Rubí SG; Wilson-Barthes M; Franco RR; Galárraga O
    BMC Public Health; 2021 Nov; 21(1):2174. PubMed ID: 34837988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preexposure Prophylaxis Implementation in a Reproductive Health Setting: Perspectives From Planned Parenthood Providers and Leaders.
    Wilbourn B; Ogburn DF; Safon CB; Galvao RW; Kershaw TS; Willie TC; Taggart T; Caldwell A; Kaplan C; Phillips N; Calabrese SK
    Health Promot Pract; 2023 Jul; 24(4):764-775. PubMed ID: 35414273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Qualitative Study of Barriers and Facilitators of PrEP Uptake Among Women in Substance Use Treatment and Syringe Service Programs.
    Tross S; Spector AY; Ertl MM; Berg H; Turrigiano E; Hoffman S
    AIDS Behav; 2023 Apr; 27(4):1162-1172. PubMed ID: 36318430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Models of HIV Pre-Exposure Prophylaxis Care Used in Title X Family Planning Clinics in the Southern U.S.
    Piper KN; Escoffery C; Sales JM; Sheth AN
    J Adolesc Health; 2021 Mar; 68(3):480-487. PubMed ID: 33160826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.